13,14,000 Equity Shares allotted Pursuant to Conversion of Warrants
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shelter Pharma Ltd has allotted 13,14,000 equity shares of face value ₹10 each upon conversion of an equivalent number of convertible warrants held by non-promoter investors. The conversion happened at ₹42.25 per share (including ₹32.25 premium), with the company receiving the remaining 75% exercise price of ₹31.6875 per share, aggregating to about ₹4.16 crore. As a result, the company's paid-up equity capital has risen from ₹11.56 crore (1.15 crore shares) to ₹12.87 crore (1.28 crore shares). This is part of a larger preferential warrant issue of 88,08,000 warrants made earlier in August 2025, of which 24,09,000 warrants remain unconverted. A total of 14 non-promoter investors participated in this tranche of conversion.
The conversion is mildly dilutive for existing shareholders as it increases the share count by about 11.4%, but it brings in fresh capital of ₹4.16 crore at a premium. With 24.09 lakh warrants still outstanding, further dilution is likely in upcoming quarters unless those lapse.